How are the institutional, ‘sophisticated’ and ‘professional’ investors that took part in this $1.50 per share capital raising feeling today?
$1.50 to 11 cents in 3.5 years.
And Starpharma have not managed to get even a single solitary new drug into the clinic despite this stellar capital raising. Now the new CEO has admitted the company is looking at going into capital preservation mode.
Is a 6 person board plus an advisor to the board really necessary for a micro cap company? Wouldn’t surprise me if CM was looking at reducing headcount across the company starting with minion staff members.
https://announcements.asx.com.au/asxpdf/20200930/pdf/44n4yy4wcyt0jd.pdf
Ann: Starpharma completes oversubscribed A$45M placement, page-41
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
-0.001(1.00%) |
Mkt cap ! $40.79M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 9.9¢ | $24.18K | 241.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2499 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 428888 | 7 |
View Market Depth
| Last trade - 16.10pm 13/06/2024 (20 minute delay) ? |
|
|||||
|
Last
10.0¢ |
Change
-0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 10.3¢ | 10.5¢ | 10.0¢ | 168392 | ||
| Last updated 15.48pm 13/06/2024 ? | |||||
| SPL (ASX) Chart |